Attenuating CD3ζ signalling by silencing two ITAMs via mutating tyrosine‐encoding sites within the CD3ζ domain can enhance the in vivo tumour elimination ability of CAR‐T cells by extending their functional persistence without compromising their potency.14 Here, CD247 is linked to neoplasm.